federica guffanti
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Dana–Farber Cancer Institute
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Dana–Farber Cancer Institute
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Alabama at Birmingham
Birmingham, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Huashan Hospital, Fudan University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas Southwestern Medical Center
Dallas, United States
Review Editor
Cancer Molecular Targets and Therapeutics
State Key Laboratory of Experimental Hematology, Peking Union Medical College Hospital (CAMS)
Tianjin, China
Review Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute (NIH)
Rockville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Alabama at Birmingham
Birmingham, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
San Diego State University
San Diego, United States
Review Editor
Cancer Molecular Targets and Therapeutics
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University
Gaotan, China
Review Editor
Cancer Molecular Targets and Therapeutics
Downstate Health Sciences University
Brooklyn, United States
Review Editor
Cancer Molecular Targets and Therapeutics
China Medical University Hospital
Taichung, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
University of Arizona
Tucson, United States
Review Editor
Cancer Molecular Targets and Therapeutics